导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 30.90% | 35/330 |
| 近一周 | -0.37% | 143/359 |
| 近一月 | 7.08% | 4/358 |
| 近一季 | 28.02% | 4/354 |
| 近半年 | 39.96% | 8/345 |
| 近一年 | 25.38% | 86/329 |
| 近两年 | 46.18% | 105/274 |
| 近三年 | 46.36% | 71/193 |
| 成立以来 | 73.28% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-9.81% 313/341 |
1.66% 227/349 |
18.38% 104/355 |
- - |
| 2024 | 1.30% 222/330 |
5.85% 123/280 |
-1.91% 215/310 |
4.21% 181/319 |
-6.38% 250/330 |
| 2023 | 8.49% 92/276 |
-9.12% 188/205 |
14.21% 44/230 |
-11.44% 226/262 |
18.04% 3/276 |
| 2022 | -18.60% 84/202 |
-18.96% 124/153 |
-12.51% 106/164 |
12.28% 3/189 |
2.25% 148/202 |
| 2021 | -21.34% 86/151 |
-2.30% 260/312 |
-1.93% 276/328 |
-6.68% 193/358 |
-12.04% 136/151 |
| 2020 | 32.56% 22/104 |
-16.96% 199/280 |
40.53% 9/295 |
-4.63% 262/299 |
19.12% 25/305 |
| 2019 | 30.31% 18/89 |
21.59% 13/258 |
-1.16% 201/268 |
-10.73% 242/253 |
21.47% 2/266 |
| 2018 | -11.51% 53/80 |
- - |
- - |
- - |
-24.17% 211/241 |
| 2017 | 23.23% 22/69 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 嘉实标普生物科技精选行业ETF(QDII) | 1.2840 | 29.58% |
| 易方达标普生物科技美元汇A | 0.2453 | 28.70% |
| 易方达标普生物科技美元汇C | 0.2420 | 28.65% |
| 易方达标普生物科技人民币C | 1.7091 | 27.95% |
| 汇添富纳斯达克生物科技ETF(QDII) | 1.4675 | 18.71% |
| 广发生物科技指数美元(QDII)C | 0.2058 | 16.69% |
| 华泰柏瑞中韩半导体ETF(QDII) | 2.3391 | 16.34% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现钞 | 1.3491 | 16.14% |
| 广发生物科技指数人民币(QDII)A | 1.4780 | 16.14% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3491 | 16.14% |
| 易方达标普生物科技人民币A VS. 天弘恒生科技指数(QDII)C(012349) |